Detalles de la búsqueda
1.
Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.
N Engl J Med
; 369(11): 1023-34, 2013 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24024839
2.
Adherence to surveillance guidelines after curative resection for stage II/III colorectal cancer.
Clin Colorectal Cancer
; 7(3): 191-6, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18621637
3.
Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.
J Clin Oncol
; 28(31): 4697-705, 2010 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20921465
4.
Survival benefit from up-front fluorouracil, leucovorin, and irinotecan/cetuximab in metastatic colorectal cancer: is it just a now-or-never result?
J Clin Oncol
; 29(31): 4207; author reply 4207-8, 2011 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21931017
5.
Impact of a pre-emptive skin treatment regimen on skin toxicities of anti-epidermal growth factor receptor monoclonal antibodies: more questions than answers.
J Clin Oncol
; 28(27): e474; author reply e475-6, 2010 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-20585089
6.
Carcinoembryonic antigen monitoring for early detection of asymptomatic incurable metastatic colorectal cancer.
J Clin Oncol
; 25(10): 1293-4; author reply 1294, 2007 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17401025
Resultados
1 -
6
de 6
1
Próxima >
>>